DHRDANAHER CORP /DE/SEC EDGAR
Use with Claude or ChatGPT
  • Overview
  • Income statement
  • Balance sheet
  • Cash flow
  • Earnings

DANAHER CORP /DE/ (DHR) Earnings history

8 quarters held0/4 transcripts analyzed4/40 figures attested
Ask your agent: get_earnings
PeriodRevenueYoYNet incomeEPS (dil.)Filed
Q3 2026$6.6B+8.3%$1.2B$1.71Oct 20, 2026
LATESTEarnings filing (8-K)10-QFiled Oct 20, 2026, 5:43 PM ET
Earnings call · Oct 21, 2026deck
Q3 FY26YoY
Revenue$6.6B+8.3%
Net income$1.2B1+32.2%
Op income$1.2B+7.9%
EPS (dil.)$1.71+34.6%
EPS (basic)$1.75+36.7%
Gross margin58.5%+0.3pp
Op margin19.0%-0.1pp
Net margin18.3%+3.3pp
  1. [1] “Net earnings were $1.2 billion” view source

Guidance & outlook

Management guidance

Q3 2026

fy_full

eps_diluted
$8.57—$8.62

q_next

other
4—5
Q2 2026$6.3B+5.5%$870.0M$1.23Jul 20, 2026
Earnings filing (8-K)10-QFiled Jul 20, 2026, 5:55 PM ET
Earnings call · Jul 21, 2026deck
Q2 FY26YoY6M FY26
Revenue$6.3B+5.5%$12.2B
Net income$870.0M1+56.8%$1.9B
Op income$1.1B+48.3%$2.5B
EPS (dil.)$1.231+59.7%$2.68
EPS (basic)$1.23+60.0%–
Gross margin57.6%-1.7pp
Op margin18.0%+5.2pp
Net margin13.9%+4.5pp
  1. [1] “Net earnings were $870 million, or $1.23 per diluted common share, up 60% year-over-year.” view source
Q1 2026$6.0B+3.7%$1.0B$1.45Apr 21, 2026
10-QFiled Apr 20, 2026, 5:44 PM ET
Earnings call · Apr 21, 2026deck
Q1 FY26YoY
Revenue$6.0B1+3.7%
Net income$1.0B+7.9%
Op income––
EPS (dil.)$1.45+9.8%
EPS (basic)––
Net margin17.3%+0.7pp
  1. [1] “Sales $ 5,951” view source
Q4 2025––––Jan 28, 2026
10-KFiled Jan 27, 2026, 5:37 PM ET
Earnings call · Jan 28, 2026
Q4 FY25YoY
Revenue––
Net income––
Op income––
EPS (dil.)––
EPS (basic)––
Q3 2025$6.1B+4.5%$908.0M$1.27Oct 21, 2025
Earnings filing (8-K)10-QFiled Oct 20, 2025, 5:39 PM ET
Q3 FY25YoY9M FY25
Revenue$6.1B+4.5%$17.7B
Net income$908.0M+11.0%$2.4B
Op income$1.2B+20.5%$3.2B
EPS (dil.)$1.27+13.4%$3.37
EPS (basic)$1.28+13.3%$3.38
Gross margin58.2%-0.5pp
Op margin19.1%+2.5pp
Net margin15.0%+0.9pp
Q2 2025$5.9B+3.5%$555.0M$0.77Jul 22, 2025
Earnings filing (8-K)10-QFiled Jul 21, 2025, 5:47 PM ET
Q2 FY25YoY6M FY25
Revenue$5.9B+3.5%$11.7B
Net income$555.0M-38.8%$1.5B
Op income$760.0M-35.0%$2.0B
EPS (dil.)$0.77-36.9%$2.10
EPS (basic)$0.77-37.4%$2.11
Gross margin59.4%-0.3pp
Op margin12.8%-7.5pp
Net margin9.3%-6.4pp
Q1 2025––––Apr 22, 2025
10-QFiled Apr 22, 2025, 6:08 AM ET
Q1 FY25YoY
Revenue––
Net income––
Op income––
EPS (dil.)––
EPS (basic)––
Q4 2024––––Jan 29, 2025
Q4 FY24YoY
Revenue––
Net income––
Op income––
EPS (dil.)––
EPS (basic)––

IR event calendar

This company's IR event calendar has not been harvested yet — an empty result here does NOT mean the company has no IR events.

Filing coverage

66 filings indexed · 63,933 XBRL facts
FilingDatePeriodSectionsTables
10-Q2026-10-21–3879
8-K2026-10-21Q3 202680
8-K2026-10-13–20
8-K2026-08-03–40
8-K2026-07-21–90
10-Q2026-07-21–3969
8-K2026-06-03–20
8-K2026-05-07–20
8-K2026-04-29–30
10-Q2026-04-21–3747

Showing the latest 10 of 66 — the full set is in the API.

Related Research

Analysis

Why Danaher's Worst Margins in Years Hide Its Best Cash Flows

Analysis

Amphenol's 52% Growth Created a $10.5B Question. The 10-K Answers It.

Analysis

Medical Device ROIC Rankings: Why Abbott's 26% Beats Medtronic's 7% (The Gross Margin Paradox)